Seeing Is Believing
Healthcare - Sector
GMDA is currently covered by 5 analysts
Gamida Cell Ltd's activity chart (see below) currently has 18 price targets and 32 ratings on display. The stock rating distribution of GMDA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 2.38% with an average time for these price targets to be met of 1.29 days.
Highest price target for GMDA is $3, Lowest price target is $3.
Most recent stock forecast was given by JASON BUTLER from JMP on 29-Jan-2024. First documented stock forecast 20-Nov-2018.
Currently out of the existing stock ratings of GMDA, 18 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$6
2 years 5 months 9 days ago
(29-Jan-2024)
0/3 (0%)
$3.95 (192.68%)
Buy
$6
2 years 7 months 3 days ago
(05-Dec-2023)
0/5 (0%)
$4.75 (380.00%)
Buy
$7
2 years 7 months 23 days ago
(15-Nov-2023)
0/8 (0%)
$5.41 (340.25%)
Buy
$5
2 years 7 months 23 days ago
(15-Nov-2023)
0/1 (0%)
$3.31 (195.86%)
Buy
$6
$5.66 (1664.71%)
3 years 1 months 22 days ago
(16-May-2023)
1/6 (16.67%)
$3.97 (195.57%)
9
What is GMDA (Gamida Cell Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on GMDA (Gamida Cell Ltd) with a proven track record?
Which analyst has the current lower performing score on GMDA (Gamida Cell Ltd) with a proven track record?
Which analyst has the most public recommendations on GMDA (Gamida Cell Ltd)?
Which analyst is the currently most bullish on GMDA (Gamida Cell Ltd)?
Which analyst is the currently most reserved on GMDA (Gamida Cell Ltd)?